Louisiana State Employees Retirement System - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Louisiana State Employees Retirement System ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$766,446
-10.8%
27,800
-2.8%
0.02%
-5.3%
Q2 2023$859,716
-5.8%
28,600
+13.5%
0.02%
-17.4%
Q1 2023$912,996
+99463.4%
25,200
-1.9%
0.02%
-8.0%
Q4 2022$917
-99.9%
25,700
+0.4%
0.02%0.0%
Q3 2022$867,000
+12.2%
25,600
-0.8%
0.02%
+19.0%
Q2 2022$773,000
+0.7%
25,800
-0.4%
0.02%
+16.7%
Q1 2022$768,000
+2.5%
25,900
+0.8%
0.02%
+12.5%
Q4 2021$749,000
+9.7%
25,700
+0.4%
0.02%0.0%
Q3 2021$683,000
-7.2%
25,600
+7.1%
0.02%
-11.1%
Q2 2021$736,000
+17.2%
23,900
-0.4%
0.02%
+12.5%
Q1 2021$628,000
+2.8%
24,000
-1.2%
0.02%
-11.1%
Q4 2020$611,000
+20.3%
24,300
-0.4%
0.02%
-21.7%
Q3 2020$508,000
+49.4%
24,400
+70.5%
0.02%
+15.0%
Q2 2020$340,000
+30.3%
14,310
-1.4%
0.02%
+5.3%
Q1 2020$261,000
-38.9%
14,510
-19.3%
0.02%
-9.5%
Q4 2019$427,000
-19.9%
17,990
-7.3%
0.02%
-25.0%
Q3 2019$533,000
-14.3%
19,400
-0.5%
0.03%
-9.7%
Q2 2019$622,000
-9.5%
19,500
-0.5%
0.03%
-8.8%
Q1 2019$687,000
+5.5%
19,600
-0.0%
0.03%
-8.1%
Q4 2018$651,000
-43.8%
19,603
-14.8%
0.04%
-26.0%
Q3 2018$1,158,000
-16.6%
23,000
-0.9%
0.05%
-20.6%
Q2 2018$1,389,000
+32.4%
23,200
+1.3%
0.06%
+31.2%
Q1 2018$1,049,000
+19.1%
22,900
+3.6%
0.05%
+20.0%
Q4 2017$881,000
+7.4%
22,100
+7.8%
0.04%
+2.6%
Q3 2017$820,000
-7.2%
20,5000.0%0.04%
-9.3%
Q2 2017$884,000
+38.3%
20,500
+0.5%
0.04%
+34.4%
Q1 2017$639,000
+27.3%
20,400
+2.5%
0.03%
+23.1%
Q4 2016$502,000
-7.4%
19,900
-9.1%
0.03%
-10.3%
Q3 2016$542,000
+73.7%
21,900
+43.1%
0.03%
+81.2%
Q2 2016$312,000
+34.5%
15,300
+0.7%
0.02%
+33.3%
Q1 2016$232,000
+14.3%
15,200
+0.7%
0.01%
+20.0%
Q4 2015$203,000
-2.9%
15,100
+1.3%
0.01%
-9.1%
Q3 2015$209,000
-3.2%
14,900
+17.3%
0.01%
+10.0%
Q2 2015$216,00012,7000.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders